Concepedia

Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy

Othman Salim Akhtar, Karnav Modi, Jongphil Kim, Lawrence Skelson, Eric E. Smith, Mohammed Al‐Jumayli, Martine Extermann, Gabriel De Avila, Nathan H. Parker, Omar Castañeda Puglianini,

Transplantation and Cellular Therapy · 2023 · 23 citations · 27 references

DOI

Concepts

References

27

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · New England Journal of Medicine · 2021 · 2.4K citations · Full text

, , +17

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

, , +17

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.7K citations

, , +17

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

Michael Proctor, David Morrison, Dinesh Talwar et al. · European Journal of Cancer · 2011 · 746 citations

, , +13

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma

Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf et al. · New England Journal of Medicine · 2023 · 705 citations · Full text

, , +17